For our project, we explored the growth of the ASU BioDesign Clinical Testing Laboratory (ABCTL) from a standard university research lab to a COVID-19 testing facility through a business lens. The lab has pioneered the saliva-test in the Western United States. This thesis analyzes the laboratory from various business concepts and aspects. The business agility of the lab and it’s quickness to innovation has allowed the lab to enjoy great success. Looking into the future, the laboratory has a promising future and will need to answer many questions to remain the premier COVID-19 testing institution in Arizona.

Early on in the pandemic, ASU leadership recognized an opportunity to involve the Biodesign Institute in an effort to keep local communities safe. Equipped with capital investments (and expertise) in diagnostic testing, university president Michael Crow tasked Dr. Joshua LaBaer - the executive director of Biodesign - to begin mapping out the lab’s logistic capabilities and operational plan. While initially testing through nasopharyngeal swabs, the Arizona Biodesign Clinical Testing Laboratory (ABCTL) eventually developed a saliva-based COVID-19 test that demonstrated higher efficacy and resource-efficiency. By maintaining rapid turnaround times for test results, the ABCTL has helped both the university population and local community operate safely. Lauded as a highly innovative testing site, the lab proved to be an essential asset as ASU, and the world, look to return to normalcy. The purpose of this thesis is to analyze the ABCTL’s inception and development using multi-faceted approaches from the business realm. There will be five topics discussed which are: • Volume I- Stakeholder Theory and Analysis Regarding the COVID-19 Bio-design Institute at Arizona State University (Claire Agee), • Volume II- The Lab as a Business Within a University Environment (Samuel Cosgrove) • Volume III- A Managerial Economic Perspective (Michael Qian) • Volume IV- An Analysis of its Upstream Supply Chain ( Kyle Mattson) • Volume V- An Operations Management Perspective (Corinne English) After these volumes, there will be a discussion about the growth and sustainability of the laboratory looking into the future. Although the ABCTL is young,the ever-changing market dynamics leave the organization with critical decisions going forward.

This thesis analyzes the relationship between diversity within U. S. boards of directors and overall firm performance. In the summer of 2020, various political and social movements erupted, fighting against police brutality and racial violence. These events were followed by an influx of diversity, equity, and inclusion (DEI) frameworks across corporate America. It was becoming increasingly clear that diversity within company leadership was lacking. A company’s board of directors, who is responsible for creating value for shareholders, was not an accurate representation of the people it served. First, I will begin by discussing the current state of diversity in corporate boards by discussing reasons firms diversify, benefits and risks of a diverse board, and major barriers to diversification efforts. A main goal of directors is to maximize shareholder return, which prompts the question: is there a financial benefit to having directors of different backgrounds, skills, and perspectives? In the second part of my thesis, I explore the correlation of board compositions and the company’s financial performance through a study of 45 Fortune 500 companies. Previous studies have mixed results; some studies concluded that there is a positive correlation, some found a negative correlation, and others were inconclusive. While the results of my study did not demonstrate that a relationship between firm performance and diversity exists, I want to emphasize that it does not mean that diverse boards do not contribute at all to the success of the board. There are various factors that contributed to my results, but regardless of my findings, I believe that further research of this topic is necessary and will be beneficial for those in corporate governance.